Zoetis Inc. logo

Zoetis Inc. (ZTS)

Market Closed
22 Jul, 20:00
NYSE NYSE
$
74. 19
-1.16
-1.5395%
$
31.94B Market Cap
29.76 P/E Ratio
2.12% Div Yield
3.48M Volume
5.79 Eps
$ 75.35
Previous Close
Add Transaction
Day Range
73.67 76.02
Year Range
71.47 160.48
Want to track ZTS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Shareholders With Losses In Zoetis Inc Are Invited By The Schall Law Firm To Participate In A Securities Fraud Inquiry

Shareholders With Losses In Zoetis Inc Are Invited By The Schall Law Firm To Participate In A Securities Fraud Inquiry

LOS ANGELES, CA / ACCESSWIRE / August 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("Zoetis" or "the Company") (NYSE:ZTS) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Accesswire | 1 year ago
The Schall Law Firm Is Investigating Zoetis Inc For Possible Securities Law Violations And Invites Shareholders To Participate

The Schall Law Firm Is Investigating Zoetis Inc For Possible Securities Law Violations And Invites Shareholders To Participate

LOS ANGELES, CA / ACCESSWIRE / August 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("Zoetis" or "the Company") (NYSE:ZTS) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Accesswire | 1 year ago
The Schall Law Firm Is Investigating Securities Violations By Zoetis Inc And Invites Investors To Join

The Schall Law Firm Is Investigating Securities Violations By Zoetis Inc And Invites Investors To Join

LOS ANGELES, CA / ACCESSWIRE / August 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("Zoetis" or "the Company") (NYSE:ZTS) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Accesswire | 1 year ago
The Schall Law Firm Is Looking Into Securities Violations By Zoetis Inc And Urges Investors To Get In Touch

The Schall Law Firm Is Looking Into Securities Violations By Zoetis Inc And Urges Investors To Get In Touch

LOS ANGELES, CA / ACCESSWIRE / August 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("Zoetis" or "the Company") (NYSE:ZTS) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Accesswire | 1 year ago
The Schall Law Firm Is Investigating Zoetis Inc And Urges Investors With Losses To Get In Touch

The Schall Law Firm Is Investigating Zoetis Inc And Urges Investors With Losses To Get In Touch

LOS ANGELES, CA / ACCESSWIRE / August 14, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("Zoetis" or "the Company") (NYSE:ZTS) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Accesswire | 1 year ago
The Schall Law Firm Is Probing Zoetis Inc And Encourages Investors With Losses To Make Contact

The Schall Law Firm Is Probing Zoetis Inc And Encourages Investors With Losses To Make Contact

LOS ANGELES, CA / ACCESSWIRE / August 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("Zoetis" or "the Company") (NYSE:ZTS) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Accesswire | 1 year ago
Zoetis: Librela Sales Should Peak 200-300% Above Management's $1B Target

Zoetis: Librela Sales Should Peak 200-300% Above Management's $1B Target

Conservative estimates suggest Librela could easily reach management's $1 billion sales target without considering international markets or Solensia (its feline counterpart), which are included in management's target calculation. Current sales data and management commentary show rapid adoption and high customer satisfaction, with Librela alone already generating a $460 million annualized revenue run rate just one year after its U.S. launch. Librela's outperformance is likely to be a significant tailwind for Zoetis' stock price, given the market's sensitivity to news about the drug's performance.

Seekingalpha | 1 year ago
Zoetis Inc Is Under Investigation By The Schall Law Firm And Investors Who Have Incurred Losses Are Urged To Reach Out

Zoetis Inc Is Under Investigation By The Schall Law Firm And Investors Who Have Incurred Losses Are Urged To Reach Out

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("Zoetis" or "the Company") (NYSE:ZTS) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Accesswire | 1 year ago
Zoetis Inc Is Under The Schall Law Firm's Investigation And Investors With Losses Are Urged To Reach Out

Zoetis Inc Is Under The Schall Law Firm's Investigation And Investors With Losses Are Urged To Reach Out

LOS ANGELES, CA / ACCESSWIRE / August 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("Zoetis" or "the Company") (NYSE:ZTS) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Accesswire | 1 year ago
Zoetis Inc Is Being Investigated By The Schall Law Firm And Investors With Losses Are Encouraged To Make Contact

Zoetis Inc Is Being Investigated By The Schall Law Firm And Investors With Losses Are Encouraged To Make Contact

LOS ANGELES, CA / ACCESSWIRE / August 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("Zoetis" or "the Company") (NYSE:ZTS) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Accesswire | 1 year ago
Zoetis Inc Is Under Investigation By The Schall Law Firm And Investors Who Have Incurred Losses Are Urged To Reach Out

Zoetis Inc Is Under Investigation By The Schall Law Firm And Investors Who Have Incurred Losses Are Urged To Reach Out

LOS ANGELES, CA / ACCESSWIRE / August 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("Zoetis" or "the Company") (NYSE:ZTS) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Accesswire | 1 year ago
Zoetis (ZTS) Just Flashed Golden Cross Signal: Do You Buy?

Zoetis (ZTS) Just Flashed Golden Cross Signal: Do You Buy?

After reaching an important support level, Zoetis (ZTS) could be a good stock pick from a technical perspective. ZTS surpassed resistance at the 20-day moving average, suggesting a short-term bullish trend.

Zacks | 1 year ago
Loading...
Load More